FDA Inspection 1266836 — Department of Defense - Air Force

Department of Defense - Air Force — FEI 1577551

The FDA completed an inspection of Department of Defense - Air Force on April 14, 2025 in Dayton, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 14, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Dayton, OH (United States)

Citations

IDCFRDescription
923421 CFR 630.40(c)Notification w/in 8 weeks